199 results on '"Ferrannini A."'
Search Results
2. Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies
3. Sex-specific differences in cytokine signaling pathways in circulating monocytes of cardiovascular disease patients
4. Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance
5. Evaluation of renal glucose uptake with [18F]FDG-PET: Methodological advancements and metabolic outcomes
6. Measuring the compliance of management system in manufacturing SMEs: An integrated model
7. Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4
8. SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI)
9. Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes
10. Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population
11. SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
12. Industry 4.0 policy from a sociotechnical perspective: The case of German competence centres
13. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study
14. Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry
15. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
16. Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study
17. Sodium-glucose transporter inhibition in heart failure: from an unexpected side effect to a novel treatment possibility
18. Serum sclerostin and glucose homeostasis: No association in healthy men. Cross-sectional and prospective data from the EGIR-RISC study
19. Industrial policy for sustainable human development in the post-Covid19 era
20. Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes
21. Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
22. Plasma N-acetylaspartate: Development and validation of a quantitative assay based on HPLC-MS-MS and sample derivatization
23. New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspective
24. 32 - Physiology of Insulin Secretion
25. Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man
26. Tracking the SDGs in an ‘integrated’ manner: A proposal for a new index to capture synergies and trade-offs between and within goals
27. Quantification of d-mannose in plasma: Development and validation of a reliable and accurate HPLC-MS-MS method
28. SMIM1 absence is associated with reduced energy expenditure and excess weight
29. microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function
30. Adipose tissue and skeletal muscle insulin-mediated glucose uptake in insulin resistance: role of blood flow and diabetes
31. Sleeping oxygen saturation, rapid eye movement sleep, and the adaptation of postprandial metabolic function in insulin sensitive and resistant individuals without diabetes
32. High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals
33. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response
34. Mechanisms linking empagliflozin to cardiovascular and renal protection
35. Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
36. Genetic backgrounds determine brown remodeling of white fat in rodents
37. Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance
38. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis
39. A “systems medicine” approach to the study of non-alcoholic fatty liver disease
40. Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: A randomised, double-blind, crossover study (eXtRa)
41. Contributors
42. Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ
43. β-Cell function in type 2 diabetes
44. The threshold shift paradigm of obesity: evidence from surgically induced weight loss
45. HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease
46. Impact of mild to moderate reductions of glomerular filtration rate on coronary artery disease severity
47. Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases
48. CXCR3, CXCL10 and type 1 diabetes
49. Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus
50. Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: Modulation by peroxisome proliferator-activated receptor γ agonists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.